Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
Nov. 30, 2022
Nov. 30, 2021
Current Assets    
Cash and cash equivalents $ 1,703,958 $ 8,263,088
Marketable securities 17,620 75,412
Accounts receivable (net of allowance for doubtful accounts of $3,078,439 and $2,781,668, respectively) 6,043,941 5,253,173
Prepaid expenses 566,557 558,413
Inventory, current portion 851,230 921,213
Other current assets 426,879 711,208
Total current assets 9,610,185 15,782,507
Property and Equipment-net 13,603,115 3,230,204
Noncurrent Assets    
Duke license agreement, net 13,691,028 14,651,802
Intangible assets, net 1,463,312 1,559,693
Inventory, net of current portion 9,275,344 9,695,363
Goodwill 1,941,411 1,941,411
Deferred tax assets 13,742,399 12,010,133
Operating lease right-of-use asset 606,034 916,493
Deposits and other assets, net 647,226 566,470
Total noncurrent assets 41,674,754 41,649,365
Total assets 64,888,054 60,662,076
Current Liabilities    
Accounts payable 1,605,301 1,489,774
Accrued expenses 3,585,810 3,057,386
Note payable 150,527 1,898,065
Line Of credit 2,272,728 0
Current portion of operating lease liability 297,691 312,067
Current portion of Duke license agreement liability 1,983,036 4,957,591
Deferred revenue 9,586,327 9,358,696
Total current liabilities 19,481,420 21,073,579
Other Liabilities    
Deferred revenue, net of current portion 36,000,059 31,274,214
Contingent consideration 1,162,704 727,371
Note payable, net of current portion and debt issuance costs 8,579,875 0
Operating lease long-term liability 313,298 610,989
Long-term liability - revenue sharing agreements 875,000 875,000
Total other liabilities 46,930,936 35,404,183
Total liabilities 66,412,356 56,477,762
Commitments and contingencies (Note 12) 0 0
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 14,665,772 issued and 8,557,326 outstanding as of November 30, 2021 and 13,633,638 issued and 7,545,613 outstanding as of November 30, 2020) 148,480 146,658
Additional paid-in capital 42,597,380 41,586,583
Treasury stock, at cost (22,632,649) (20,812,734)
Accumulated deficit (21,637,513) (16,736,193)
Total stockholders' equity (deficit) (1,524,302) 4,184,314
Total liabilities and stockholders' equity (deficit) 64,888,054 60,662,076
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Noncurrent Assets    
Investment $ 308,000 308,000
Duke University [Member]    
Other Liabilities    
Duke license agreement liability   $ 1,916,609